BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6265832)

  • 1. [Vasoactive intestinal polypeptide in digestive processes in the Verner Morrison syndrome].
    Leonardi R; Toffoli C; Rigamonti L; Rigamonti D; Gambassi G; Greco A; Ghirlanda G
    Minerva Med; 1981 Jun; 72(26):1707-11. PubMed ID: 6265832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
    Fahrenkrug J; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide and gastrin-producing islet cell carcinoma.
    Judge DM; Demers LM; Nahrwold DL; Dickman PS; Petrokubi RJ; Trapukdi S
    Arch Pathol Lab Med; 1977 May; 101(5):262-5. PubMed ID: 192171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
    Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
    Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
    Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
    Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
    Devine BL; Carmichael HA; Russell RI; Joffe SN
    Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.
    Bloom SR; Polak JM
    Clin Endocrinol (Oxf); 1976; 5 Suppl():223S-228S. PubMed ID: 212228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of diarrhea and WDHA syndrome].
    Ozawa Y; Shishiba Y
    Nihon Rinsho; 1982; 40(5):1151-7. PubMed ID: 6288980
    [No Abstract]   [Full Text] [Related]  

  • 9. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
    Meuwese-Arends MT; Yap SH; Van Tongeren JH
    Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
    [No Abstract]   [Full Text] [Related]  

  • 10. Streptozotocin treatment of a pancreatic tumour producing VIP and gastrin associated with Verner-Morrison syndrome.
    Oberg K; Boström H; Fahrenkrug J; Dymling JF; Shaffalitsky de Muckadell OB; Lundqvist G
    Acta Med Scand; 1979; 206(3):223-7. PubMed ID: 227234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical aspects of gut hormone-producing tumors (author's transl)].
    Yamaguchi K; Abe K
    Horumon To Rinsho; 1979; 27(12):1363-78. PubMed ID: 44490
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasoactive intestinal peptide producing neuroblastoma.
    Cooney DR; Voorhess ML; Fisher JE; Brecher M; Karp MP; Jewett TC
    J Pediatr Surg; 1982 Dec; 17(6):821-25. PubMed ID: 6298396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of gastrointestinal hormones.
    Lamers CB
    Neth J Med; 1978; 21(2):77-82. PubMed ID: 206847
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diarrheic syndrome and beta cell tumors of the pancreas: the Verner-Morrison syndrome: report of a case].
    Machado MC; Bettarello A; Mott CB; Bacchella T; da Cunha JE
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Apr; 36(2):78-85. PubMed ID: 6275483
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pancreatic cholera--Verner-Morrison syndrome].
    Rajewska J
    Wiad Lek; 1975 May; 28(9):751-5. PubMed ID: 166520
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vipomas].
    Dupont C
    Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The vaso-active intestinal polypeptide in Verner-Morrison syndrome].
    Seif FJ; Sadowski P; Heni F; Fischer R; Bloom SR; Polak JM
    Dtsch Med Wochenschr; 1975 Feb; 100(9):399-405. PubMed ID: 163727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Verner-Morrison syndrome].
    Fahrenkrug J; Pedersen JH; Schaffalitzky de Muckadell OB; Stadil F
    Ugeskr Laeger; 1981 Oct; 143(44):2881-4. PubMed ID: 6275594
    [No Abstract]   [Full Text] [Related]  

  • 19. [The significance of gastrointestinal hormones in gastroenterological practice].
    Domschke W
    Fortschr Med; 1978 Apr; 96(14):739-42. PubMed ID: 640556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Verner-Morrison syndrome (1 case with determination of vasoactive intestinal peptide (V.I.P.) and electron microscope study)].
    Lescut J; Mazzuca M; Hanon D; Ribet M
    Lille Med; 1979 Mar; 24(3):189-93. PubMed ID: 226822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.